Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 9,55 M
EBIT 2016 -20,3 M
Net income 2016 -23,4 M
Debt 2016 -
Yield 2016 -
Sales 2017 13,4 M
EBIT 2017 -11,1 M
Net income 2017 -18,6 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 44,9x
Capi. / Sales2017 32,1x
Capitalization 429 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company.Its develops autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally... 
More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : - Investor Rating :
More Ratings
Latest news on CYTORI THERAPEUTICS INC
07/28 CYTORI THERAPEUTICS : Cell Therapy™ Phase I Trial Reports Maxillofacial Bo..
07/25 CYTORI THERAPEUTICS : What Do All These Investigator-Initiated Studies Mean to C..
07/14 CYTORI THERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant, Finan..
07/07 CYTORI THERAPEUTICS : Cell Therapy Receives Limited Approval for Osteoarthritis ..
07/07 CYTORI THERAPEUTICS : ATHENA Trial for Chronic Ischemic Cardiovascular Disease
06/28 CYTORI THERAPEUTICS : Cell Therapy Receives Limited Approval for Osteoarthritis ..
06/23 CYTORI THERAPEUTICS : Announces Expiration of Rights Offering and Estimated Gros..
06/23 CYTORI THERAPEUTICS : Closes Rights Offering for Gross Proceeds of $17.1 Million
06/23 CYTORI THERAPEUTICS : Cell Therapy™ Leads to Improved Function and Reduced..
06/16 CYTORI THERAPEUTICS : Presentation of Twelve Month Pilot Trial Data of Cytori® C..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
07/28DJZIMMER BIOMET : Boosts Bottom End of Earnings Forecast as Loss Narrows
07/28 Weak China sales drag down Smith & Nephew profits
07/27DJAlere Faces Criminal Probe Over Medicare, Medicaid Billing
07/26DJBAXTER : Results Boosted by Growth in Hospital Products Segment
07/25DJBAXTER : CFOs Turn to Consultants as Challenges Mount
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
05/10 Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2016 Results - Earnings Ca..
05/10 Cytori Therapeutics EPS in-line, beats on revenue
05/10 Cytori Cell Therapy an Orphan Drug in Europe for scleroderma-related hand dys..
05/09 Notable earnings after Tuesday?s close
03/24 Cytori's late-stage study of ECCS-50 in scleroderma 50% enrolled; study to co..
Advertisement
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 7,83 $
Spread / Average Target 261%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Marc H. Hedrick President, Chief Executive Officer & Director
David M. Rickey Chairman
Tiago Girão CFO, Vice President & Head-Investor Relations
Steven Kesten Chief Medical Officer & Executive Vice President
John K. Fraser Chief Scientist
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTORI THERAPEUTICS IN..-4.14%429
MEDTRONIC PLC13.92%122 220
BAXTER INTERNATIONAL I..25.87%26 520
ZIMMER BIOMET HOLDINGS..27.83%26 186
TERUMO CORP19.54%16 497
C R BARD INC18.10%16 434
More Results